Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB · Entity 5650 | See Remarks | August 19, 2024 | August 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Report date August 19, 2024 · Filed August 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 869,730 |
Reported balance
After 2024-08-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-08-19 · Sale · Disposed 26,760 · Balance 869,730 F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2: This sale price represents the weighted average sale price of the shares sold ranging from $1.58 to $1.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3: Includes 3,128 shares purchased on March 1, 2024 under the Company's 2010 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 208 |
Reported balance
Holding disclosure · report date 2024-08-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 208 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2: This sale price represents the weighted average sale price of the shares sold ranging from $1.58 to $1.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: Includes 3,128 shares purchased on March 1, 2024 under the Company's 2010 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2024 Filed Aug 20, 2024 21:27 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 26,760 | $1.59 | $42,601.92 |
DisclosureSEC source: 0001299130-24-000173 · wk-form4_1724189215.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869,730 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $1.58 to $1.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 3,128 shares purchased on March 1, 2024 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:25 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 461,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-24-000040 · wk-form4_1708982738.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 893,362 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2025, 2026, 2027, and 2028, provided that the Reporting Person continues to serve through each applicable vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 23:20 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 15,498 | $5.96 | $92,337.08 |
DisclosureSEC source: 0001299130-24-000027 · wk-form4_1708557646.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,824 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $5.69 to $6.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,656 shares purchased on September 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 20:36 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | SaleCommon Stock | 25,936 | $10.60 | $274,843.79 |
DisclosureSEC source: 0001299130-23-000109 · wf-form4_169239096419083.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,666 F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $10.51 to $10.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:39 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 164,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-23-000034 · certent-form4.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,602 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date. F2 · balance_after: Includes 5,832 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 16:29 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantStock Option (right to buy) · Derivative | 600,000 | $0.00 Strike: $8.00 | $0.00 |
DisclosureSEC source: 0001299130-22-000106 · certent-form4.xml · derivative · entry 2 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2032-08-16 F2 · derivative.exercise_date: 1/4 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 16:29 UTC | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB · Entity 5650 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001299130-22-000106 · certent-form4.xml · nonDerivative · entry 1 Eidel Jeff · CIK 0001942024 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,570 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on August 16th of each of 2023, 2024, 2025, and 2026, provided that the Reporting Person continues to serve through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.